Abstract
Objective To evaluate the clinical efficacy of intravitreal injection of ranibizumab combined with panretinal photocoagulation for the treatment of nonproliferative diabetic retinopathy(DR). Methods The data of 104 eyes of 65 cases of nonproliferative DR were retrospectively analyzed.All cases received intravitreal injection of ranibizumab combined with panretinal photocoagulation.The followed-up time was 6 months. Results The visual acuity improved in 42 eyes, no changed in 55 eyes. The efficacy rate was 93.37%.The results of FFA showed markedly effective in 42 cases (40.38%), effective in 34 cases (32.69%) and ineffective in 24 cases (22.93%). The results of OCT showed that, the macular retinal thickness were (367.56±78.34)μm before treatment and(225.12±35.78)μm half a year after treatment. The difference was statistically significant (P<0.05). Conclusion Intravitreal injection of ranibizumab combined with panretinal photocoagulation for the treatment of nonprotiferative DR is effective. Key words: Retinopathy, diabetic, nonproliterative; Ranibizumab, intravitreal injection; Photocoagulation, panretinal
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Chinese Journal of Ocular Trauma and Occupational Eye Disease
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
